Skip to main content
Springer Nature Link
Log in

Immunobiology and Host Response to HEV

  • Chapter
  • First Online:
Hepatitis E Virus

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1417))

Abstract

Hepatitis E virus (HEV) usually causes acute self-limiting hepatitis but sometimes leads to chronic infection in immunocompromised persons. HEV is not directly cytopathic. Immunologically mediated events after HEV infection are believed to play important roles in the pathogenesis and clearance of infection. The anti-HEV antibody responses have been largely clarified since the determination of major antigenic determinant of HEV, which is located in the C-terminal portion of ORF2. This major antigenic determinant also forms the conformational neutralization epitopes. Robust anti-HEV immunoglobulin M (IgM) and IgG responses usually develop 3–4 weeks after infection in experimentally infected nonhuman primates. In humans, potent specific IgM and IgG responses occur in the very early phase of the disease and are critical in eliminating the virus, in concert with the innate and adaptive T-cell immune responses. Testing anti-HEV IgM is valuable in the diagnosis of acute hepatitis E. The long-term persistence and protection of anti-HEV IgG provide the basis for estimating the prevalence of HEV infection and for the development of a hepatitis E vaccine. Although human HEV has four genotypes, all the viral strains are considered to belong to a single serotype. It is becoming increasingly clear that the innate and adaptive T-cell immune responses play critical roles in the clearance of the virus. Potent and multispecific CD4+ and CD8+ T cell responses to the ORF2 protein occur in patients with acute hepatitis E, and weaker HEV-specific CD4+ and CD8+ T cell responses appear to be associated with chronic hepatitis E in immunocompromised individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (Canada)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

aa:

Amino acid

anti-HEV:

Antibodies directed against HEV

ELISA:

Enzyme-linked immunosorbent assay

HEV:

Hepatitis E virus

IFN:

Interferon

IL:

Interleukin

IRF:

IFN regulatory factor

ISG:

Interferon-stimulated gene

NF-κB:

Nuclear factor kappa-B

NK cells:

Natural killer cells

NKT cells:

Natural killer T-cells

NLRP3:

NOD-like receptor protein 3

ORF:

Open reading frame

PAMP:

Pathogen-associated motif pattern

PBMC:

Peripheral blood mononuclear cell

RIG-I:

Retinoic acid-inducible gene I

SDS-PAGE:

Sodium dodecyl sulfate polyacrylamide gel electrophoresis

STAT:

Signal transducers and activators of transcription

TGF-β:

Transforming growth factor beta

TLR:

Toll-like receptor

TNF-α:

Tumor necrosis factor alpha

UTR:

Untranslated region

References

  1. Purdy MA, Harrison TJ, Jameel S, Meng XJ, Okamoto H, Van der Poel WHM et al (2017) ICTV virus taxonomy profile: hepeviridae. J Gen Virol 98(11):2645–2646

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Nagashima S, Takahashi M, Kobayashi T, Nishizawa T, Nishiyama T, Primadharsini PP et al (2017) Characterization of the quasi-enveloped hepatitis E virus particles released by the cellular exosomal pathway. J Virol 91(22):e00822–e00817

    Article  PubMed  PubMed Central  Google Scholar 

  3. Grimm D, Heeg M, Thimme R (2013) Hepatitis B virus: from immunobiology to immunotherapy. Clin Sci (Lond) 124(2):77–85

    Article  CAS  PubMed  Google Scholar 

  4. Malcolm P, Dalton H, Hussaini HS, Mathew J (2007) The histology of acute autochthonous hepatitis E virus infection. Histopathology 51(2):190–194

    Article  CAS  PubMed  Google Scholar 

  5. Kureljušić B, Aleksić-Kovačević S, Savić B, Prodanović R, Jezdimirović N, Milićević V et al (2021) Morphological and immunophenotypic characteristics of the liver of swine naturally infected with hepatitis E virus. Vet Ital 57(4):287–295

    PubMed  Google Scholar 

  6. Yang Y, Shi R, Soomro MH, Hu F, Du F, She R (2018) Hepatitis E virus induces hepatocyte apoptosis via mitochondrial pathway in Mongolian Gerbils. Front Microbiol 9:460

    Article  PubMed  PubMed Central  Google Scholar 

  7. John L, Thomas S, Herchenroder O, Putzer BM, Schaefer S (2011) Hepatitis E virus ORF2 protein activates the pro-apoptotic gene CHOP and anti-apoptotic heat shock proteins. PLoS One 6(9):e25378

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Soomro MH, Shi R, She R, Yang Y, Hu F, Li H (2016) Antigen detection and apoptosis in Mongolian gerbil’s kidney experimentally intraperitoneally infected by swine hepatitis E virus. Virus Res 213:343–352

    Article  CAS  PubMed  Google Scholar 

  9. Geng Y, Zhao C, Huang W, Harrison TJ, Zhang H, Geng K et al (2016) Detection and assessment of infectivity of hepatitis E virus in urine. J Hepatol 64(1):37–43

    Article  PubMed  Google Scholar 

  10. Tian J, Shi R, Xiao P, Liu T, She R, Wu Q et al (2019) Hepatitis E virus induces brain injury probably associated with mitochondrial apoptosis. Front Cell Infect Microbiol 9:433

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Pérez-García F, Vázquez-Morón S, Burgueño-García I, José Muñoz-Gómez M, Zea-Sevilla MA, Calero M et al (2022) Hepatitis E virus seroprevalence is associated with neurodegenerative disorders in older people with dementia: a case-control study. J Infect Dis:jiac268. https://doi.org/10.1093/infdis/jiac268

  12. Tian D, Li W, Heffron CL, Wang B, Mahsoub HM, Sooryanarain H et al (2022) Hepatitis E virus infects brain microvascular endothelial cells, crosses the blood-brain barrier, and invades the central nervous system. Proc Natl Acad Sci U S A 119(24):e2201862119

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Yang W, Chen S, Mickael HK, Xu L, Xia Y, Cong C et al (2021) Uterine injury caused by genotype 4 hepatitis E virus infection based on a BALB/c mice model. Viruses 13(10):1950

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhang F, Wang J, Cheng J, Zhang X, He Q, Zhaochao L et al (2022) Clinical features of sporadic hepatitis E virus infection in pregnant women in Shanghai, China. J Infect 84(1):64–70

    Article  CAS  PubMed  Google Scholar 

  15. Arya RP, Arankalle VA (2014) Toll like receptors in self-recovering hepatitis E patients with or without pregnancy. Hum Immunol 75(12):1147–1154

    Article  CAS  PubMed  Google Scholar 

  16. Majumdar M, Ratho RK, Chawla Y, Singh MP (2015) Role of TLR gene expression and cytokine profiling in the immunopathogenesis of viral hepatitis E. J Clin Virol 73:8–13

    Article  CAS  Google Scholar 

  17. Devhare PB, Desai S, Lole KS (2016) Innate immune responses in human hepatocyte-derived cell lines alter genotype 1 hepatitis E virus replication efficiencies. Sci Rep 6:26827

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Choi YH, Zhang X, Tran C, Skinner B (2018) Expression profiles of host immune response-related genes against HEV genotype 3 and genotype 1 infections in rhesus macaques. J Viral Hepat 25(8):986–995

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sehgal R, Patra S, David P, Vyas A, Khanam A, Hissar S et al (2015) Impaired monocyte-macrophage functions and defective Toll-like receptor signaling in hepatitis E virus-infected pregnant women with acute liver failure. Hepatology 62(6):1683–1696

    Article  CAS  PubMed  Google Scholar 

  20. Yu C, Boon D, McDonald SL, Myers TG, Tomioka K, Nguyen H et al (2010) Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences. J Virol 84(21):11264–11278

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Dong C, Zafrullah M, Mixson-Hayden T, Dai X, Liang J, Meng J et al (2012) Suppression of interferon-alpha signaling by hepatitis E virus. Hepatology 55(5):1324–1332

    Article  CAS  PubMed  Google Scholar 

  22. Todt D, François C, Anggakusuma, Behrendt P, Engelmann M, Knegendorf L et al (2016) Antiviral activities of different interferon types and subtypes against hepatitis E virus replication. Antimicrob Agents Chemother 60(4):2132–2139

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Yin X, Li X, Ambardekar C, Hu Z, Lhomme S, Feng Z (2017) Hepatitis E virus persists in the presence of a type III interferon response. PLoS Pathog 13(5):e1006417

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wu X, Dao Thi VL, Liu P, Takacs CN, Xiang K, Andrus L et al (2018) Pan-genotype hepatitis E virus replication in stem cell-derived hepatocellular systems. Gastroenterology 154(3):663–674.e667

    Article  PubMed  Google Scholar 

  25. Wang W, Wang Y, Qu C, Wang S, Zhou J, Cao W et al (2018) The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response. Hepatology 67(6):2096–2112

    Article  CAS  PubMed  Google Scholar 

  26. Murata K, Kang JH, Nagashima S, Matsui T, Karino Y, Yamamoto Y et al (2020) IFN-λ3 as a host immune response in acute hepatitis E virus infection. Cytokine 125:154816

    Article  CAS  PubMed  Google Scholar 

  27. Nan Y, Yu Y, Ma Z, Khattar SK, Fredericksen B, Zhang YJ (2014) Hepatitis E virus inhibits type I interferon induction by ORF1 products. J Virol 88(20):11924–11932

    Article  PubMed  PubMed Central  Google Scholar 

  28. Nan Y, Ma Z, Wang R, Yu Y, Kannan H, Fredericksen B et al (2014) Enhancement of interferon induction by ORF3 product of hepatitis E virus. J Virol 88(15):8696–8705

    Article  PubMed  PubMed Central  Google Scholar 

  29. Zhang F, Qi Y, Harrison TJ, Luo B, Zhou Y, Li X et al (2014) Hepatitis E genotype 4 virus from feces of monkeys infected experimentally can be cultured in PLC/PRF/5 cells and upregulate host interferon-inducible genes. J Med Virol 86(10):1736–1744

    Article  CAS  PubMed  Google Scholar 

  30. Xu L, Wang W, Li Y, Zhou X, Yin Y, Wang Y et al (2017) RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production. Hepatology 65(6):1823–1839

    Article  CAS  PubMed  Google Scholar 

  31. Bagdassarian E, Doceul V, Pellerin M, Demange A, Meyer L, Jouvenet N et al (2018) The amino-terminal region of hepatitis E virus ORF1 containing a methyltransferase (Met) and a papain-like cysteine protease (PCP) domain counteracts type I interferon response. Viruses 10(12):726

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kang S, Choi C, Choi I, Han KN, Rho SW, Choi J et al (2018) Hepatitis E virus methyltransferase inhibits type I interferon induction by targeting RIG-I. J Microbiol Biotechnol 28(9):1554–1562

    Article  CAS  PubMed  Google Scholar 

  33. Sooryanarain H, Heffron CL, Meng XJ (2020) The U-rich untranslated region of the hepatitis E virus induces differential type I and type III interferon responses in a host cell-dependent manner. MBio 11(1):e03103–e03119

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Qian Z, Yang C, Xu L, Mickael HK, Chen S, Zhang Y et al (2022) Hepatitis E virus-encoded microRNA promotes viral replication by inhibiting type I interferon. FASEB J 36(1):e22104

    Article  CAS  PubMed  Google Scholar 

  35. Srivastava R, Aggarwal R, Bhagat MR, Chowdhury A, Naik S (2008) Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. J Viral Hepat 15(12):910–916

    Article  CAS  PubMed  Google Scholar 

  36. Abravanel F, Barrague H, Dorr G, Saune K, Peron JM, Alric L et al (2016) Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients. J Infect 72(6):723–730

    Article  PubMed  Google Scholar 

  37. Prabhu SB, Gupta P, Durgapal H, Rath S, Gupta SD, Acharya SK et al (2011) Study of cellular immune response against Hepatitis E virus (HEV). J Viral Hepat 18(8):587–594

    Article  CAS  PubMed  Google Scholar 

  38. Jung S, Seo DJ, Yeo D, Wang Z, Min A, Zhao Z et al (2020) Experimental infection of hepatitis E virus induces pancreatic necroptosis in miniature pigs. Sci Rep 10(1):12022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Prusty BK, Hedau S, Singh A, Kar P, Das BC (2007) Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol Med 13(9–10):518–526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Surjit M, Varshney B, Lal SK (2012) The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-kappaB activity by blocking ubiquitination mediated proteasomal degradation of IkappaBalpha in human hepatoma cells. BMC Biochem 13:7

    Article  CAS  PubMed  Google Scholar 

  41. Xu J, Wu F, Tian D, Wang J, Zheng Z, Xia N (2014) Open reading frame 3 of genotype 1 hepatitis E virus inhibits nuclear factor-kappa B signaling induced by tumor necrosis factor-alpha in human A549 lung epithelial cells. PLoS One 9(6):e100787

    Article  PubMed  PubMed Central  Google Scholar 

  42. Li Y, Yu P, Kessler AL, Shu J, Liu X, Liang Z et al (2022) Hepatitis E virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetable. Hepatology 75(1):196–212

    Article  CAS  PubMed  Google Scholar 

  43. Peron JM, Danjoux M, Kamar N, Missoury R, Poirson H, Vinel JP et al (2007) Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from South-West France. Virchows Arch 450(4):405–410

    Article  PubMed  Google Scholar 

  44. El Costa H, Gouilly J, Abravanel F, Bahraoui E, Peron JM, Kamar N et al (2021) Effector memory CD8 T cell response elicits Hepatitis E Virus genotype 3 pathogenesis in the elderly. PLoS Pathog 17(2):e1009367

    Article  PubMed  PubMed Central  Google Scholar 

  45. Thakur V, Ratho RK, Singh MP, Chawla Y, Taneja S (2022) NLRP3 Inflammasome activation is a prognostic marker of recovery in HEV-infected patients. Curr Microbiol 79(2):44

    Article  CAS  PubMed  Google Scholar 

  46. Debes JD, Groothuismink ZMA, Doukas M, de Man RA, Boonstra A (2019) Immune dissociation during acute hepatitis E infection. Int J Infect Dis 87:39–42

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Kaur M, Hyams KC, Purdy MA, Krawczynski K, Ching WM, Fry KE et al (1992) Human linear B-cell epitopes encoded by the hepatitis E virus include determinants in the RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A 89(9):3855–3858

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Khudyakov YE, Khudyakova NS, Fields HA, Jue D, Starling C, Favorov MO et al (1993) Epitope mapping in proteins of hepatitis E virus. Virology 194(1):89–96

    Article  CAS  PubMed  Google Scholar 

  49. Khudyakov YE, Favorov MO, Jue DL, Hine TK, Fields HA (1994) Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology 198(1):390–393

    Article  CAS  Google Scholar 

  50. Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE et al (1990) Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247(4948):1335–1339

    Article  CAS  PubMed  Google Scholar 

  51. Yarbough PO, Tam AW, Fry KE, Krawczynski K, McCaustland KA, Bradley DW et al (1991) Hepatitis E virus: identification of type-common epitopes. J Virol 65(11):5790–5797

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Mast EE, Alter MJ, Holland PV, Purcell RH (1998) Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 27(3):857–861

    Article  CAS  PubMed  Google Scholar 

  53. Balayan MS (1997) Epidemiology of hepatitis E virus infection. J Viral Hepat 4(3):155–165

    Article  CAS  PubMed  Google Scholar 

  54. Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ et al (1997) Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 35(5):1244–1247

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Zhou YH, Purcell RH, Emerson SU (2004) An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine 22(20):2578–2585

    Article  CAS  PubMed  Google Scholar 

  56. Zhou YH, Purcell RH, Emerson SU (2005) A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus. Vaccine 23(24):3157–3165

    Article  CAS  PubMed  Google Scholar 

  57. Meng J, Dubreuil P, Pillot J (1997) A new PCR-based seroneutralization assay in cell culture for diagnosis of hepatitis E. J Clin Microbiol 35(6):1373–1377

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Meng J, Dai X, Chang JC, Lopareva E, Pillot J, Fields HA et al (2001) Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 288(2):203–211

    Article  CAS  Google Scholar 

  59. Li F, Zhuang H, Kolivas S, Locarnini SA, Anderson DA (1994) Persistent and transient antibody responses to hepatitis E virus detected by western immunoblot using open reading frame 2 and 3 and glutathione S-transferase fusion proteins. J Clin Microbiol 32(9):2060–2066

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Li F, Torresi J, Locarnini SA, Zhuang H, Zhu W, Guo X et al (1997) Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are masked. J Med Virol 52(3):289–300

    Article  CAS  PubMed  Google Scholar 

  61. Li TC, Yamakawa Y, Suzuki K, Tatsumi M, Razak MA, Uchida T et al (1997) Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 71(10):7207–7213

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Xing L, Kato K, Li T, Takeda N, Miyamura T, Hammar L et al (1999) Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes. Virology 265(1):35–45

    Article  CAS  PubMed  Google Scholar 

  63. Purcell RH, Nguyen H, Shapiro M, Engle RE, Govindarajan S, Blackwelder WC et al (2003) Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 21(19–20):2607–2615

    Article  CAS  PubMed  Google Scholar 

  64. Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, Thapa N et al (2007) Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 356(9):895-903 105

    Article  Google Scholar 

  65. Arankalle VA, Lole KS, Deshmukh TM, Srivastava S, Shaligram US (2009) Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes. Vaccine 27(7):1032–1039

    Article  CAS  PubMed  Google Scholar 

  66. Huang WJ, Zhang HY, Harrison TJ, Lan HY, Huang GY, Wang YC (2009) Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4. Arch Virol 154(3):481–488

    Article  CAS  PubMed  Google Scholar 

  67. Kamili S, Spelbring J, Carson D, Krawczynski K (2004) Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J Infect Dis 189(2):258–264

    Article  CAS  PubMed  Google Scholar 

  68. Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ et al (2005) A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 23(22):2893–2901

    Article  CAS  PubMed  Google Scholar 

  69. Li TC, Suzaki Y, Ami Y, Dhole TN, Miyamura T, Takeda N (2004) Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. Vaccine 22(3–4):370–377

    Article  CAS  PubMed  Google Scholar 

  70. Tsarev SA, Tsareva TS, Emerson SU, Govindarajan S, Shapiro M, Gerin JL et al (1994) Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A 91(21):10198–10202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Zhang M, Emerson SU, Nguyen H, Engle R, Govindarajan S, Blackwelder WC et al (2002) Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques. Vaccine 20(27–28):3285–3291

    Article  CAS  PubMed  Google Scholar 

  72. Zhang M, Emerson SU, Nguyen H, Engle RE, Govindarajan S, Gerin JL et al (2001) Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine 20(5–6):853–857

    Article  CAS  PubMed  Google Scholar 

  73. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ et al (2010) Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376(9744):895–902

    Article  CAS  PubMed  Google Scholar 

  74. Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ et al (2015) Long-term efficacy of a hepatitis E vaccine. N Engl J Med 372(10):914–922

    Article  CAS  PubMed  Google Scholar 

  75. Avellon A, Morago L, Garcia-Galera del Carmen M, Munoz M, Echevarria JM (2015) Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection. J Med Virol 87(11):1934–1939

    Article  CAS  PubMed  Google Scholar 

  76. Gu G, Huang H, Zhang L, Bi Y, Hu Y, Zhou YH (2015) Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years. BMC Infect Dis 15:560

    Article  PubMed  PubMed Central  Google Scholar 

  77. Holm DK, Moessner BK, Engle RE, Zaaijer HL, Georgsen J, Purcell RH et al (2015) Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion 55(7):1662–1667

    Article  CAS  PubMed  Google Scholar 

  78. Kmush BL, Labrique AB, Dalton HR, Ahmed ZB, Ticehurst JR, Heaney CD et al (2015) Two generations of “gold standards”: the impact of a decade in hepatitis E virus testing innovation on population seroprevalence. Am J Trop Med Hyg 93(4):714–717

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Norder H, Karlsson M, Mellgren A, Konar J, Sandberg E, Lasson A et al (2016) Diagnostic performance of five assays for anti-hepatitis E virus IgG and IgM in a large cohort study. J Clin Microbiol 54(3):549–555

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Jameel S, Zafrullah M, Ozdener MH, Panda SK (1996) Expression in animal cells and characterization of the hepatitis E virus structural proteins. J Virol 70(1):207–216

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Li SW, Zhang J, He ZQ, Gu Y, Liu RS, Lin J et al (2005) Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem 280(5):3400–3406

    Article  CAS  PubMed  Google Scholar 

  82. Graff J, Zhou YH, Torian U, Nguyen H, St Claire M, Yu C et al (2008) Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. J Virol 82(3):1185–1194

    Article  CAS  PubMed  Google Scholar 

  83. Xu M, Behloul N, Wen J, Zhang J, Meng J (2016) Role of asparagine at position 562 in dimerization and immunogenicity of the hepatitis E virus capsid protein. Infect Genet Evol 37:99–107

    Article  CAS  PubMed  Google Scholar 

  84. Liu Z, Behloul N, Baha S, Wei W, Tao W, Zhang T et al (2020) Role of the C-terminal cysteines in virus-like particle formation and oligomerization of the hepatitis E virus ORF2 truncated proteins. Virology 544:1–11

    Article  CAS  PubMed  Google Scholar 

  85. Pan JS, Zhang K, Zhou J, Wu C, Zhuang H, Zhou YH (2010) Application of truncated immunodominant polypeptide from hepatitis E virus (HEV) ORF2 in an assay to exclude nonspecific binding in detecting anti-HEV immunoglobulin M. J Clin Microbiol 48(3):779–784

    Article  CAS  PubMed  Google Scholar 

  86. Tsarev SA, Emerson SU, Tsareva TS, Yarbough PO, Lewis M, Govindarajan S et al (1993) Variation in course of hepatitis E in experimentally infected cynomolgus monkeys. J Infect Dis 167(6):1302–1306

    Article  CAS  PubMed  Google Scholar 

  87. Yu C, Engle RE, Bryan JP, Emerson SU, Purcell RH (2003) Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay. Clin Diagn Lab Immunol 10(4):579–586

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Zhang J, Ge SX, Huang GY, Li SW, He ZQ, Wang YB et al (2003) Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model. J Med Virol 71(4):518–526

    Article  CAS  PubMed  Google Scholar 

  89. Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP et al (1983) Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 20(1):23–31

    Article  CAS  PubMed  Google Scholar 

  90. Chauhan A, Jameel S, Dilawari JB, Chawla YK, Kaur U, Ganguly NK (1993) Hepatitis E virus transmission to a volunteer. Lancet 341(8838):149–150

    Article  CAS  PubMed  Google Scholar 

  91. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B et al (2014) Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 384(9956):1766–1773

    Article  PubMed  Google Scholar 

  92. Tedder RS, Tettmar KI, Brailsford SR, Said B, Ushiro-Lumb I, Kitchen A et al (2016) Virology, serology, and demography of hepatitis E viremic blood donors in South East England. Transfusion 56(6 Pt 2):1529–1536

    Article  PubMed  Google Scholar 

  93. Kimura Y, Gotoh A, Katagiri S, Hoshi Y, Uchida S, Yamasaki A et al (2014) Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes. Blood Transfus 12(1):103–106

    PubMed  PubMed Central  Google Scholar 

  94. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M et al (2008) A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 48(7):1368–1375

    Article  CAS  PubMed  Google Scholar 

  95. Matsui T, Kang JH, Matsubayashi K, Yamazaki H, Nagai K, Sakata H et al (2015) Rare case of transfusion-transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: viral dynamics from onset to recovery. Hepatol Res 45(6):698–704

    Article  CAS  PubMed  Google Scholar 

  96. Fuse K, Matsuyama Y, Moriyama M, Miyakoshi S, Shibasaki Y, Takizawa J et al (2015) Late onset post-transfusion hepatitis E developing during chemotherapy for acute promyelocytic leukemia. Intern Med 54(6):657–661

    Article  PubMed  Google Scholar 

  97. Seriwatana J, Shrestha MP, Scott RM, Tsarev SA, Vaughn DW, Myint KS et al (2002) Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M. Clin Diagn Lab Immunol 9(5):1072–1078

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Koshy A, Grover S, Hyams KC, Shabrawy MA, Pacsa A, al-Nakib B et al (1996) Short-term IgM and IgG antibody responses to hepatitis E virus infection. Scand J Infect Dis 28(5):439–441

    Article  CAS  PubMed  Google Scholar 

  99. Chandra NS, Sharma A, Malhotra B, Rai RR (2010) Dynamics of HEV viremia, fecal shedding and its relationship with transaminases and antibody response in patients with sporadic acute hepatitis E. Virol J 7:213

    Article  PubMed  PubMed Central  Google Scholar 

  100. Myint KS, Endy TP, Shrestha MP, Shrestha SK, Vaughn DW, Innis BL et al (2006) Hepatitis E antibody kinetics in Nepalese patients. Trans R Soc Trop Med Hyg 100(10):938–941

    Article  CAS  PubMed  Google Scholar 

  101. Lu J, Huang Y, Wang P, Li Q, Li Z, Jiang J et al (2021) Dynamics of hepatitis E virus (HEV) Antibodies and development of a multifactorial model to improve the diagnosis of HEV infection in resource-limited settings. J Clin Microbiol 59(2):e02321–e02320

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Arankalle VA, Chadha MS, Chobe LP (1999) Long-term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virus. J Hepatol 30(2):199–204

    Article  CAS  PubMed  Google Scholar 

  103. Chadha MS, Walimbe AM, Arankalle VA (1999) Retrospective serological analysis of hepatitis E patients: a long-term follow-up study. J Viral Hepat 6(6):457–461

    Article  CAS  PubMed  Google Scholar 

  104. Zhou X, Xu B, Xu C, Huang H, Chen J, Chen S et al (2015) Dynamics of anti-HEV in mothers and their newborns from delivery to postpartum 7-12 months. Chin J Health Lab Technol 25(16):2056–2059

    Google Scholar 

  105. Chen S, Zhou Z, Wei FX, Huang SJ, Tan Z, Fang Y et al (2015) Modeling the long-term antibody response of a hepatitis E vaccine. Vaccine 33(33):4124–4129

    Article  CAS  PubMed  Google Scholar 

  106. Kmush BL, Zaman K, Yunus M, Saha P, Nelson KE, Labrique AB (2018) A ten year immunopersistence study of hepatitis E antibodies in Rural Bangladesh. Am J Epidemiol 187(7):1501–1510

    Article  PubMed  PubMed Central  Google Scholar 

  107. Kmush BL, Yu H, Huang S, Zhang X, Wu T, Nelson KE et al (2019) Long-term antibody persistence after hepatitis E virus infection and vaccination in Dongtai, China. Open Forum Infect Dis 6(4):ofz144

    Article  PubMed  PubMed Central  Google Scholar 

  108. Hasegawa I, Nakano T, Koguchi H, Jinno N, Hirashima N, Nagashima S et al (2022) Subclinical hepatitis E virus (HEV) infection detected by nucleic acid amplification test on blood donation: short-term positivity for immunoglobulin G class of antibody against HEV. Clin J Gastroenterol 15(4):750–754

    Article  PubMed  Google Scholar 

  109. Oshiro Y, Harada H, Hasegawa K, Akutsu N, Yoshizumi T, Kawagishi N et al (2021) Loss of antibodies to hepatitis E virus in organ transplant patients with hepatitis E. Hepatol Res 51(5):538–547

    Article  CAS  PubMed  Google Scholar 

  110. Takahashi M, Kusakai S, Mizuo H, Suzuki K, Fujimura K, Masuko K et al (2005) Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection. J Clin Microbiol 43(1):49–56

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Chau KH, Dawson GJ, Bile KM, Magnius LO, Sjogren MH, Mushahwar IK (1993) Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E virus infection. J Med Virol 40(4):334–338

    Article  CAS  PubMed  Google Scholar 

  112. Elkady A, Tanaka Y, Kurbanov F, Hirashima N, Sugiyama M, Khan A et al (2007) Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection. J Gastroenterol 42(11):911–917

    Article  CAS  PubMed  Google Scholar 

  113. Herremans M, Duizer E, Jusic E, Koopmans MP (2007) Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3. Clin Vaccine Immunol 14(3):276–280

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Zhang L, Pan J, Zhou J, Bi Y, Zhou YH (2010) Evaluation of specific IgA against hepatitis E virus (HEV) in the diagnosis of acute HEV infection. Chin J Health Lab Technol 20(8):1951–1953

    Google Scholar 

  115. Engle RE, Yu C, Emerson SU, Meng XJ, Purcell RH (2002) Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol 40(12):4576–4580

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Arankalle VA, Lole KS, Deshmukh TM, Chobe LP, Gandhe SS (2007) Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections. J Viral Hepat 14(6):435–445

    Article  CAS  PubMed  Google Scholar 

  117. Sanford BJ, Dryman BA, Huang YW, Feagins AR, Leroith T, Meng XJ (2011) Prior infection of pigs with a genotype 3 swine hepatitis E virus (HEV) protects against subsequent challenges with homologous and heterologous genotypes 3 and 4 human HEV. Virus Res 159(1):17–22

    Article  CAS  PubMed  Google Scholar 

  118. Dai X, Dong C, Zhou Z, Liang J, Dong M, Yang Y et al (2013) Hepatitis E virus genotype 4, Nanjing, China, 2001-2011. Emerg Infect Dis 19(9):1528–1530

    Article  PubMed  PubMed Central  Google Scholar 

  119. Arora NK, Panda SK, Nanda SK, Ansari IH, Joshi S, Dixit R et al (1999) Hepatitis E infection in children: study of an outbreak. J Gastroenterol Hepatol 14(6):572–577

    Article  CAS  PubMed  Google Scholar 

  120. Dawson GJ, Chau KH, Cabal CM, Yarbough PO, Reyes GR, Mushahwar IK (1992) Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods 38(1):175–186

    Article  CAS  PubMed  Google Scholar 

  121. Boccia D, Guthmann JP, Klovstad H, Hamid N, Tatay M, Ciglenecki I et al (2006) High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis 42(12):1679–1684

    Article  PubMed  Google Scholar 

  122. Fischer C, Hofmann M, Danzer M, Hofer K, Kaar J, Gabriel C (2015) Seroprevalence and Incidence of hepatitis E in blood donors in Upper Austria. PLoS One 10(3):e0119576

    Article  PubMed  PubMed Central  Google Scholar 

  123. Pisano MB, Blanco S, Di Cola G, Fantilli AC, Martínez Wassaf MG, Carrizo LH et al (2022) Hepatitis E virus in blood donors from Argentina: a possible source of viral infection? Travel Med Infect Dis 48:102355

    Article  CAS  PubMed  Google Scholar 

  124. Takikawa Y, Miyamoto Y, Onodera M, Kuroda H, Kasai K, Miyasaka A et al (2012) Icteric acute hepatitis E with no response of immunoglobulin M class anti-hepatitis E virus antibody. Hepatol Res 42(11):1146–1149

    Article  PubMed  Google Scholar 

  125. Abravanel F, Lhomme S, Chapuy-Regaud S, Peron JM, Alric L, Rostaing L et al (2015) Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients. J Clin Virol 70:101–104

    Article  CAS  PubMed  Google Scholar 

  126. Fogeda M, de Ory F, Avellon A, Echevarria JM (2009) Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. J Clin Virol 45(3):259–261

    Article  CAS  PubMed  Google Scholar 

  127. Kim HS, Jeong SH, Jang JH, Myung HJ, Kim JW, Bang SM et al (2011) Coinfection of hepatitis A virus genotype IA and IIIA complicated with autoimmune hemolytic anemia, prolonged cholestasis, and false-positive immunoglobulin M anti-hepatitis E virus: a case report. Korean J Hepatol 17(4):323–327

    Article  PubMed  PubMed Central  Google Scholar 

  128. Meky FA, Stoszek SK, Abdel-Hamid M, Selim S, Abdel-Wahab A, Mikhail N et al (2006) Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Clin Infect Dis 42(5):628–633

    Article  PubMed  Google Scholar 

  129. Srivastava R, Aggarwal R, Jameel S, Puri P, Gupta VK, Ramesh VS et al (2007) Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. Viral Immunol 20(1):56–65

    Article  CAS  PubMed  Google Scholar 

  130. Husain MM, Aggarwal R, Kumar D, Jameel S, Naik S (2011) Effector T cells immune reactivity among patients with acute hepatitis E. J Viral Hepat 18(10):e603–e608

    Article  CAS  PubMed  Google Scholar 

  131. Kemming J, Gundlach S, Panning M, Huzly D, Huang J, Lütgehetmann M et al (2022) Mechanisms of CD8+ T cell failure in chronic hepatitis E virus infection. J Hepatol 77:978. https://doi.org/10.1016/j.jhep.2022.05.019

    Article  CAS  PubMed  Google Scholar 

  132. Taherkhani R, Farshadpour F, Makvandi M, Rajabi Memari H, Samarbafzadeh AR, Sharifi N et al (2015) Cytokine profiles and cell proliferation responses to truncated ORF2 protein in Iranian patients recovered from hepatitis E infection. J Trop Med 2015:523560

    Article  PubMed  PubMed Central  Google Scholar 

  133. Shata MT, Barrett A, Shire NJ, Abdelwahab SF, Sobhy M, Daef E et al (2007) Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay. J Immunol Methods 328(1–2):152–161

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Choi Y, Zhang X, Skinner B (2019) Analysis of IgG anti-HEV antibody protective levels during hepatitis E virus reinfection in experimentally infected rhesus macaques. J Infect Dis 219(6):916–924

    Article  CAS  PubMed  Google Scholar 

  135. Kulkarni SP, Sharma M, Tripathy AS (2019) Antibody and memory B cell responses in hepatitis E recovered individuals, 1-30 years post hepatitis E virus infection. Sci Rep 9(1):4090

    Article  PubMed  PubMed Central  Google Scholar 

  136. Brown A, Halliday JS, Swadling L, Madden RG, Bendall R, Hunter JG et al (2016) Characterization of the specificity, functionality, and durability of host T-cell responses against the full-length hepatitis E virus. Hepatology 64(6):1934–1950

    Article  CAS  PubMed  Google Scholar 

  137. Al-Ayoubi J, Behrendt P, Bremer B, Suneetha PV, Gisa A, Rinker F et al (2018) Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis E. Liver Int 38(2):266–277

    Article  CAS  PubMed  Google Scholar 

  138. Soon CF, Behrendt P, Todt D, Manns MP, Wedemeyer H, Sällberg Chen M et al (2019) Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E. J Hepatol 71(4):673–684

    Article  CAS  PubMed  Google Scholar 

  139. Gisa A, Suneetha PV, Behrendt P, Pischke S, Bremer B, Falk CS et al (2016) Cross-genotype-specific T-cell responses in acute hepatitis E virus (HEV) infection. J Viral Hepat 23(4):305–315

    Article  CAS  PubMed  Google Scholar 

  140. Aggarwal R, Shukla R, Jameel S, Agrawal S, Puri P, Gupta VK et al (2007) T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J Viral Hepat 14(4):283–292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  141. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S (2009) Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 361(10):1025–1027

    Article  CAS  PubMed  Google Scholar 

  142. Geng Y, Zhang H, Huang W, Harrision TJ, Geng K, Li Z et al (2014) Persistent hepatitis e virus genotype 4 infection in a child with acute lymphoblastic leukemia. Hepat Mon 14(1):e15618

    PubMed  PubMed Central  Google Scholar 

  143. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J et al (2008) Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358(8):811–817

    Article  CAS  PubMed  Google Scholar 

  144. Wang Y, Liu S, Pan Q, Zhao J (2020) Chronic hepatitis E in an immunocompetent patient. Clin Res Hepatol Gastroenterol 44(3):e66–e68

    Article  PubMed  Google Scholar 

  145. Suneetha PV, Pischke S, Schlaphoff V, Grabowski J, Fytili P, Gronert A et al (2012) Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 55(3):695–708

    Article  CAS  PubMed  Google Scholar 

  146. Bremer W, Blasczyk H, Yin X, Salinas E, Grakoui A, Feng Z et al (2021) Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques. J Hepatol 75(3):557–564

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Experimental Medicine and Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China

    Yi-Hua Zhou

  2. Department of Infectious Diseases, Second Hospital of Nanjing, Southeast University School of Medicine, Nanjing, China

    Hong Zhao

Authors
  1. Yi-Hua Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hong Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, China

    Youchun Wang

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zhou, YH., Zhao, H. (2023). Immunobiology and Host Response to HEV. In: Wang, Y. (eds) Hepatitis E Virus. Advances in Experimental Medicine and Biology, vol 1417. Springer, Singapore. https://doi.org/10.1007/978-981-99-1304-6_7

Download citation

Publish with us

Policies and ethics

Search

Navigation